Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653638 · ClinicalTrials.gov registry record · Early Phase 1
Blood Brain Flow and Exercise
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
NCT02653638 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 80 participants.
The verdict
NCT02653638, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
Cerebral vasodilator responses to CO2 will be measured in young healthy adults, healthy sedentary older adults, and healthy exercise trained older adults. This variable will be examined before and after administering the cyclooxygenase inhibitor indomethacin, which has been shown to blunt cerebral vasodilator responses. In addition, the investigators will examine these counter-regulatory hemodynamic mechanisms to hypoperfusion caused by indomethacin.
Interventions
- OTHER Control
- DRUG Indomethacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02653638
The ClinicalTrials.gov registry entry for NCT02653638 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02653638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02653638 about?
NCT02653638 is a clinical study titled "Blood Brain Flow and Exercise". Cerebral vasodilator responses to CO2 will be measured in young healthy adults, healthy sedentary older adults, and healthy exercise trained older adults. This variable will be examined before and after administering the cyclooxygenase inhibitor indomethacin, which has been shown to blunt cerebral v...
What is the current status of trial NCT02653638?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2016-06. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02653638?
The interventions under investigation include: Control (OTHER), Indomethacin (DRUG).
Who is sponsoring clinical trial NCT02653638?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.